MedTrace Logo

Effects of Aspirin and Low Molecular Weight Heparin in IVF Outcome.

NCT01924104 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2013-08-16

No results posted yet for this study

Summary

The purpose of the study is to determine whether low-dose aspirin and low molecular weight heparin improve the implantation and pregnancy rates in patients with repeated implantation failures in IVF cycle.

Conditions

  • To Investigate the Effects of Low Dose Aspirin and Low Molecular Weight Heparin in IVF Out Come

Interventions

DRUG

Low molecular weight heparin

2500 mIU/day, subcutaneously

DRUG

Low dose aspirin

75 mg/day, orally

DRUG

Heparin & aspirin

Aspirin (70 mg/day, orally) \& heparin (40 mg/day, subcutaneously)

OTHER

NaCl

Equivalent volume of NaCl 0.9%, subcutaneously

Sponsors & Collaborators

  • Dr.Vandana Bansal

    lead OTHER

Principal Investigators

  • Vandana Bansal, MS DGO PhD · Arpit Test Tube Baby Centre, Vandana Women's Hospital, Jeevan Jyoti Hospital & Research Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
19 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-08-31
Completion
2014-12-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01924104 on ClinicalTrials.gov